Wilson C L, Dlabal P W, McGuire S A
Am Heart J. 1979 Oct;98(4):440-6. doi: 10.1016/0002-8703(79)90248-5.
To determine which method of surgical therapy might be optimal for patients with anomalous left coronary artery from the pulmonary artery (ALCAPA), a follow-up study was performed. Twenty-nine teenagers and adults who had ALCAPA diagnosed during life at age 13 years or older were identified mainly by literature search. Recent follow-up was obtained on all. Thirteen treated by ALCAPA ligation alone (Group A), were followed a mean of 9.2 years postoperately (range 1 to 15 years). There was no operative mortality. Three Group A patients died suddenly; a mean of five years (range 2 to 7 years) postoperatively. Sixteen patients treated by simultaneous ALCAPA ligation and saphenous vein graft (SVG) from aorta to left coronary artery (Group B) were followed a mean of five years (range 0 to 11 years) with one intraoperative death and no late mortality. Using the generalized Wilcoxon test for single censored samples, there was no significant difference in survival at any postoperative year when comparing both Groups A and B. The late appearance of sudden death in three Group A patients and no late deaths in Group B patients suggests that ligation and SVG, or its equivalent, may be the therapy of choice.
为了确定哪种手术治疗方法可能最适合患有肺动脉起源异常左冠状动脉(ALCAPA)的患者,我们进行了一项随访研究。主要通过文献检索确定了29名在13岁及以上被诊断为ALCAPA的青少年和成年人。对所有人都进行了近期随访。13例仅接受ALCAPA结扎治疗的患者(A组),术后平均随访9.2年(范围1至15年)。无手术死亡。A组有3例患者突然死亡,术后平均5年(范围2至7年)。16例同时接受ALCAPA结扎和从主动脉到左冠状动脉的大隐静脉移植(SVG)治疗的患者(B组),平均随访5年(范围0至11年),有1例术中死亡,无晚期死亡。使用单样本截尾的广义Wilcoxon检验,比较A组和B组时,任何术后年份的生存率均无显著差异。A组3例患者出现晚期猝死,而B组患者无晚期死亡,这表明结扎和SVG或其等效方法可能是首选治疗方法。